EndoPRO Solutions is focused on addressing the global Obesity epidemic affecting 15 million people in the U.S alone. The Company was founded by a gastroenterologist who was inspired by other non-surgical disease treatments such as stents for heart disease. Addressing this vast unmet need with a non-surgical medical device solution was the motivation behind the Company. We have uniquely combined two clinically proven methods in our proprietary device–the Antral Anchor. Our novel, first-of-its-kind medical device is patent protected and offers leapfrog technology in the bariatric (weight loss) market. In addition to obtaining issued U.S. patents, the Company has a complete and detailed product development plan from a proven, reputable third-party medical device contractor. We are ready to make this concept a reality once we secure our funding.
Diet and exercise is the first option for everyone trying to lose weight. Strict calorie counting and fad regimens typical fail. Diet pills, occasionally prescribed for the short term, provide transient benefits and are often associated with dangerous side effects. Surgical weight loss operations are drastic, costly, and risky!
What is needed is a non-surgical option that is: safe, effective, affordable, and reversible. EndoPRO’s Antral Anchor provides the Solution. The proprietary design has engineered away many of the safety concerns inherent with competitors–nothing is sewn into the stomach and there are no free-floating objects that could migrate and cause a blockage. Two clinically proven weight loss modalities–intestinal barrier and stomach balloon–are uniquely combined. This synergistic dual action provides an enhanced weight loss effect. The Antral Anchor is 80% less expensive than a surgical equivalent option. After weight loss goal is reached or 12-18 months after placement, the device may be removed endoscopically with no alteration to the original stomach anatomy!
Of the 15 million morbidly obese people in the U.S., only 200,000 (less than 2%) each year undergo a surgical weight loss procedure. Our non-surgical device has 95% gross profit margins. These two facts reveal a tremendous market and lucrative business opportunity!
John Mark Provenza,